NVAX EBITDA

Novavax Inc · EBITDA

NVAX logo

NVAX EBITDA

Latest reported-$205.59M
NVAX TTM EBITDA (-$4.80M → -$205.59M)
High-resolution chart · PNG

NVAX ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novavax Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-205,591,000
-42,125,000
492,327,000
409,996,000
495,569,000
554,895,000
-108,044,000
-216,355,000
-228,252,000
-337,057,000
-487,390,000
-498,286,000
-534,618,000
-1,101,787,000
-604,713,000
-1,252,536,000
-1,405,857,000
-1,250,135,000
-1,680,748,000
-1,031,062,000
-915,780,000
-588,883,000
-397,873,000
-254,901,000
-76,997,000
-98,134,000
-114,474,000
-130,572,000
-155,938,000
-160,339,000
-162,977,000
-164,227,000
-162,659,000
-162,520,000
-159,880,000
-166,064,000
-189,028,000
-224,532,000
-259,170,000
-286,689,000
-257,671,000
-202,403,000
-152,560,000
-105,322,000
-92,459,000
-90,167,000
-80,535,000
-61,939,000
-57,859,000
-53,360,000
-49,475,000
-45,353,000
-37,641,000
-30,814,000
-28,336,000
-22,676,000
-19,795,000
-20,205,000
-20,237,000
-21,391,000
-27,421,000
-30,018,000
-34,114,000
-43,533,000
-41,500,000
-40,504,000
-36,189,000
-31,228,000
-32,983,000
-33,299,000
-33,467,000
-27,865,000
-27,052,000
-27,813,000
-28,641,000
-31,694,000
-28,177,000
-25,712,000
-21,892,000
-8,397,000
-4,270,000
-2,325,000
-5,696,000
-21,861,000
-22,110,000
-24,553,000
-21,411,000
-15,140,000
-16,277,000
-13,994,000
-14,867,000
-16,730,000
-20,420,000
-21,305,000
-21,363,000
-18,889,000
-14,063,000
-9,576,000
-5,766,000
-8,428,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.